Sign up to save your podcasts
Or
Share March 2020 Editor's Choice: PARP Inhibitor Maintenance Therapy after Initial Chemotherapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
March 2020 Editor's Choice: PARP Inhibitor Maintenance Therapy after Initial Chemotherapy
Editor's Choice Paper: "Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making" and Editorial Paper: "Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations" Hosted by: Dr. Deborah K. Armstrong and Featuring: Dr. Eskander, Dr. Cearbhaill, Dr. Pothuri
View all episodes
By Gynecologic Oncology
5
1818 ratings
Editor's Choice Paper: "Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making" and Editorial Paper: "Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations" Hosted by: Dr. Deborah K. Armstrong and Featuring: Dr. Eskander, Dr. Cearbhaill, Dr. Pothuri
More shows like Listen to Gynecologic Oncology
View all
The NPR Politics Podcast
25,787 Listeners
Pod Save America
86,656 Listeners
The Daily
110,617 Listeners
Up First from NPR
55,911 Listeners
SGO on the GO
33 Listeners
John Mark Comer Teachings
1,763 Listeners
Good Hang with Amy Poehler
7,841 Listeners